Selected research
Industry Research
Nifedipine API Industry Research Report 2026
Market perspective
The global Nifedipine API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Nifedipine API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Nifedipine API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Nifedipine API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Nifedipine API include Bayer AG, Cipla Ltd, Delmar Chemicals Inc., Dipharma Francis S.r.l, Moehs Iberica S.L., Sumika Fine Chemicals Co. Ltd., Tecoland Corp, Teva Pharmaceuticals and Siyao Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Nifedipine API market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nifedipine API Market by Company
Bayer AG
Cipla Ltd
Delmar Chemicals Inc.
Dipharma Francis S.r.l
Moehs Iberica S.L.
Sumika Fine Chemicals Co. Ltd.
Tecoland Corp
Teva Pharmaceuticals
Siyao Pharmaceuticals
Xiyue Pharmaceutical
Zhong'an Pharmaceutical
Yantai Luyin Pharmaceutical
Qingyang Pharmaceutical
Nifedipine API Segment by Type
98% Nifedipine API
99% Nifedipine API
99.9% Nifedipine API
Nifedipine API Segment by Application
Nifedipine Controlled Release Tablets
Nifedipine Extended Release Tablets
Nifedipine API Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nifedipine API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nifedipine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nifedipine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nifedipine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 98% Nifedipine API
- 99% Nifedipine API
- 99.9% Nifedipine API
Applications
- Nifedipine Controlled Release Tablets
- Nifedipine Extended Release Tablets
Companies covered
- Bayer AG
- Cipla Ltd
- Delmar Chemicals Inc.
- Dipharma Francis S.r.l
- Moehs Iberica S.L.
- Sumika Fine Chemicals Co. Ltd.
- Tecoland Corp
- Teva Pharmaceuticals
- Siyao Pharmaceuticals
- Xiyue Pharmaceutical
- Zhong'an Pharmaceutical
- Yantai Luyin Pharmaceutical
- Qingyang Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Nifedipine API Market Size (2021-2032)
- 2.2.2 Global Nifedipine API Sales (2021-2032)
- 2.2.3 Global Nifedipine API Market Average Price (2021-2032)
- 2.3 Nifedipine API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 98% Nifedipine API
- 2.3.3 99% Nifedipine API
- 2.3.4 99.9% Nifedipine API
- 2.4 Nifedipine API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Nifedipine Controlled Release Tablets
- 2.4.3 Nifedipine Extended Release Tablets
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nifedipine API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Nifedipine API Sales (K Tons) of Manufacturers (2021-2026)
- 3.3 Global Nifedipine API Revenue of Manufacturers (2021-2026)
- 3.4 Global Nifedipine API Average Price by Manufacturers (2021-2026)
- 3.5 Global Nifedipine API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Nifedipine API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Nifedipine API, Product Type & Application
- 3.8 Global Manufacturers of Nifedipine API, Established Date
- 3.9 Global Nifedipine API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bayer AG
- 4.1.1 Bayer AG Company Information
- 4.1.2 Bayer AG Business Overview
- 4.1.3 Bayer AG Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bayer AG Nifedipine API Product Portfolio
- 4.1.5 Bayer AG Recent Developments
- 4.2 Cipla Ltd
- 4.2.1 Cipla Ltd Company Information
- 4.2.2 Cipla Ltd Business Overview
- 4.2.3 Cipla Ltd Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Cipla Ltd Nifedipine API Product Portfolio
- 4.2.5 Cipla Ltd Recent Developments
- 4.3 Delmar Chemicals Inc.
- 4.3.1 Delmar Chemicals Inc. Company Information
- 4.3.2 Delmar Chemicals Inc. Business Overview
- 4.3.3 Delmar Chemicals Inc. Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Delmar Chemicals Inc. Nifedipine API Product Portfolio
- 4.3.5 Delmar Chemicals Inc. Recent Developments
- 4.4 Dipharma Francis S.r.l
- 4.4.1 Dipharma Francis S.r.l Company Information
- 4.4.2 Dipharma Francis S.r.l Business Overview
- 4.4.3 Dipharma Francis S.r.l Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Dipharma Francis S.r.l Nifedipine API Product Portfolio
- 4.4.5 Dipharma Francis S.r.l Recent Developments
- 4.5 Moehs Iberica S.L.
- 4.5.1 Moehs Iberica S.L. Company Information
- 4.5.2 Moehs Iberica S.L. Business Overview
- 4.5.3 Moehs Iberica S.L. Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Moehs Iberica S.L. Nifedipine API Product Portfolio
- 4.5.5 Moehs Iberica S.L. Recent Developments
- 4.6 Sumika Fine Chemicals Co. Ltd.
- 4.6.1 Sumika Fine Chemicals Co. Ltd. Company Information
- 4.6.2 Sumika Fine Chemicals Co. Ltd. Business Overview
- 4.6.3 Sumika Fine Chemicals Co. Ltd. Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sumika Fine Chemicals Co. Ltd. Nifedipine API Product Portfolio
- 4.6.5 Sumika Fine Chemicals Co. Ltd. Recent Developments
- 4.7 Tecoland Corp
- 4.7.1 Tecoland Corp Company Information
- 4.7.2 Tecoland Corp Business Overview
- 4.7.3 Tecoland Corp Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Tecoland Corp Nifedipine API Product Portfolio
- 4.7.5 Tecoland Corp Recent Developments
- 4.8 Teva Pharmaceuticals
- 4.8.1 Teva Pharmaceuticals Company Information
- 4.8.2 Teva Pharmaceuticals Business Overview
- 4.8.3 Teva Pharmaceuticals Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Teva Pharmaceuticals Nifedipine API Product Portfolio
- 4.8.5 Teva Pharmaceuticals Recent Developments
- 4.9 Siyao Pharmaceuticals
- 4.9.1 Siyao Pharmaceuticals Company Information
- 4.9.2 Siyao Pharmaceuticals Business Overview
- 4.9.3 Siyao Pharmaceuticals Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Siyao Pharmaceuticals Nifedipine API Product Portfolio
- 4.9.5 Siyao Pharmaceuticals Recent Developments
- 4.10 Xiyue Pharmaceutical
- 4.10.1 Xiyue Pharmaceutical Company Information
- 4.10.2 Xiyue Pharmaceutical Business Overview
- 4.10.3 Xiyue Pharmaceutical Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Xiyue Pharmaceutical Nifedipine API Product Portfolio
- 4.10.5 Xiyue Pharmaceutical Recent Developments
- 4.11 Zhong'an Pharmaceutical
- 4.11.1 Zhong'an Pharmaceutical Company Information
- 4.11.2 Zhong'an Pharmaceutical Business Overview
- 4.11.3 Zhong'an Pharmaceutical Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Zhong'an Pharmaceutical Nifedipine API Product Portfolio
- 4.11.5 Zhong'an Pharmaceutical Recent Developments
- 4.12 Yantai Luyin Pharmaceutical
- 4.12.1 Yantai Luyin Pharmaceutical Company Information
- 4.12.2 Yantai Luyin Pharmaceutical Business Overview
- 4.12.3 Yantai Luyin Pharmaceutical Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Yantai Luyin Pharmaceutical Nifedipine API Product Portfolio
- 4.12.5 Yantai Luyin Pharmaceutical Recent Developments
- 4.13 Qingyang Pharmaceutical
- 4.13.1 Qingyang Pharmaceutical Company Information
- 4.13.2 Qingyang Pharmaceutical Business Overview
- 4.13.3 Qingyang Pharmaceutical Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Qingyang Pharmaceutical Nifedipine API Product Portfolio
- 4.13.5 Qingyang Pharmaceutical Recent Developments
5 Global Nifedipine API Market Scenario by Region
- 5.1 Global Nifedipine API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Nifedipine API Sales by Region: 2021-2032
- 5.2.1 Global Nifedipine API Sales by Region: 2021-2026
- 5.2.2 Global Nifedipine API Sales by Region: 2027-2032
- 5.3 Global Nifedipine API Revenue by Region: 2021-2032
- 5.3.1 Global Nifedipine API Revenue by Region: 2021-2026
- 5.3.2 Global Nifedipine API Revenue by Region: 2027-2032
- 5.4 North America Nifedipine API Market Facts & Figures by Country
- 5.4.1 North America Nifedipine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Nifedipine API Sales by Country (2021-2032)
- 5.4.3 North America Nifedipine API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Nifedipine API Market Facts & Figures by Country
- 5.5.1 Europe Nifedipine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Nifedipine API Sales by Country (2021-2032)
- 5.5.3 Europe Nifedipine API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Nifedipine API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Nifedipine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Nifedipine API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Nifedipine API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Nifedipine API Market Facts & Figures by Country
- 5.7.1 South America Nifedipine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Nifedipine API Sales by Country (2021-2032)
- 5.7.3 South America Nifedipine API Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Nifedipine API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Nifedipine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Nifedipine API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Nifedipine API Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Nifedipine API Sales by Type (2021-2032)
- 6.1.1 Global Nifedipine API Sales by Type (2021-2032) & (K Tons)
- 6.1.2 Global Nifedipine API Sales Market Share by Type (2021-2032)
- 6.2 Global Nifedipine API Revenue by Type (2021-2032)
- 6.2.1 Global Nifedipine API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Nifedipine API Revenue Market Share by Type (2021-2032)
- 6.3 Global Nifedipine API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Nifedipine API Sales by Application (2021-2032)
- 7.1.1 Global Nifedipine API Sales by Application (2021-2032) & (K Tons)
- 7.1.2 Global Nifedipine API Sales Market Share by Application (2021-2032)
- 7.2 Global Nifedipine API Revenue by Application (2021-2032)
- 7.2.1 Global Nifedipine API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Nifedipine API Revenue Market Share by Application (2021-2032)
- 7.3 Global Nifedipine API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Nifedipine API Value Chain Analysis
- 8.1.1 Nifedipine API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Nifedipine API Production Mode & Process
- 8.2 Nifedipine API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Nifedipine API Distributors
- 8.2.3 Nifedipine API Customers
9 Global Nifedipine API Analyzing Market Dynamics
- 9.1 Nifedipine API Industry Trends
- 9.2 Nifedipine API Industry Drivers
- 9.3 Nifedipine API Industry Opportunities and Challenges
- 9.4 Nifedipine API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst